Enrolling Clinical Studies

shutterstock_1902095974.jpg

NON-ALCOHOLIC FATTY LIVER DISEASE (NASH)

This study will evaluate the long term efficacy and safety of a medication in patients with non alcoholic and non cirrhotic fatty liver disease.

Requirements:

• Men & Women 18 years of age or older
• Positive history of fatty liver from FibroScan test or/and Liver biopsy
• FibroScan results not older than 3 month or/and Liver biopsy not older than 2 years
• Not suffering of cirrhosis related of alcohol abuse
• No history of other liver condition
• No history of heart condition or other major health condition

Study Duration:

This duration of this study is 3 years.

Compensation:

Eligible participants will receive financial compensation of $75
per visit and $600 per biopsy.